Login / Signup

The COVID-19 International Drug Pregnancy Registry (COVID-PR): Protocol Considerations.

Diego F WyszynskiAris T PapageorghiouCheryl RenzTorri D MetzSonia Hernandez-Diaz
Published in: Drug safety (2023)
ClinicalTrials.gov: NCT05013632. EU PAS EUPAS42517.
Keyphrases
  • coronavirus disease
  • sars cov
  • randomized controlled trial
  • respiratory syndrome coronavirus
  • preterm birth
  • emergency department
  • pregnant women
  • drug induced